https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-01 / Gan To Kagaku Ryoho 2014 Oct;41(10):1295-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-01 / Gan To Kagaku Ryoho 2014 Oct;41(10):1295-72014-10-01 00:00:002014-10-01 00:00:00[The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer – 229 clinical cases]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-29 / Int J Mol Sci 2014 Sep;15(10):17380-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-29 / Int J Mol Sci 2014 Sep;15(10):17380-952014-09-29 00:00:002019-02-15 09:17:09Hyperthermia induces apoptosis through endoplasmic reticulum and reactive oxygen species in human osteosarcoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-28 / Cancer Immunol. Immunother. 2015 Jan;64(1):51-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-28 / Cancer Immunol. Immunother. 2015 Jan;64(1):51-92014-09-28 00:00:002019-02-15 08:45:30Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-26 / Cancer Invest. 2014 Nov;32(9):451-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-26 / Cancer Invest. 2014 Nov;32(9):451-72014-09-26 00:00:002019-07-01 06:51:38Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-26 / Biochim. Biophys. Acta 2015 Jan;1853(1):52-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-26 / Biochim. Biophys. Acta 2015 Jan;1853(1):52-622014-09-26 00:00:002019-02-15 09:17:08Thermotolerance induced at a mild temperature of 40°C alleviates heat shock-induced ER stress and apoptosis in HeLa cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-26 / Cancer Gene Ther. 2014 Nov;21(11):463-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-26 / Cancer Gene Ther. 2014 Nov;21(11):463-712014-09-26 00:00:002019-02-15 09:21:22Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-2576
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-25762014-09-25 00:00:002014-09-25 00:00:00Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-25 / Cell Death Dis 2014 Sep;5:e1426
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-25 / Cell Death Dis 2014 Sep;5:e14262014-09-25 00:00:002014-09-25 00:00:00MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-23 / J Transl Med 2014 Sep;12:262
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-23 / J Transl Med 2014 Sep;12:2622014-09-23 00:00:002019-02-15 08:49:57Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-19 / Int J Med Sci 2014;11(12):1240-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-19 / Int J Med Sci 2014;11(12):1240-72014-09-19 00:00:002019-02-15 09:21:21Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells